Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations
Abstract Background Recently, the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26) was recommended for the assessment of adverse effects after the treatment of prostate cancer without clear reasons. This decision encouraged us to review the questionnaire development from the UCLA P...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | BMC Urology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12894-017-0302-7 |
id |
doaj-6a0e61cef7814cdf80f87f06633741e8 |
---|---|
record_format |
Article |
spelling |
doaj-6a0e61cef7814cdf80f87f06633741e82020-11-25T00:21:03ZengBMCBMC Urology1471-24902017-12-0117111110.1186/s12894-017-0302-7Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinationsKarol Axcrona0Rasmus Nilsson1Bjørn Brennhovd2Øystein Sørebø3Sophie D. Fosså4Alv A. Dahl5Department of Urology, Akershus University HospitalDepartment of Urology, Telemark HospitalDepartment of Urology, Oslo University Hospital, The Norwegian Radium HospitalSchool of Business and Social Sciences, University College of Southeast NorwayNational Resource Center for Late Effects after Cancer Treatment, Oslo University Hospital, The Norwegian Radium HospitalNational Resource Center for Late Effects after Cancer Treatment, Oslo University Hospital, The Norwegian Radium HospitalAbstract Background Recently, the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26) was recommended for the assessment of adverse effects after the treatment of prostate cancer without clear reasons. This decision encouraged us to review the questionnaire development from the UCLA Prostate Cancer Index (UCLA-PCI) to the EPIC-16 CP with a focus on psychometric properties. We also reviewed PubMed for papers concerning such properties of the EPIC-26 since 2012 (latest review in 2011). Finally, we examined the psychometric properties of the EPIC-26 in a sample of Norwegian males treated with robot-assisted laparoscopic prostatectomy (RALP). Methods This study used three methods: (1) Comparison of the content of the UCLA-PCI, EPIC-50, EPIC-26, and EPIC-16 CP; (2) Review of EPIC-26 and EPIC-16 CP papers in PubMed from 2012 to 2016, identifying papers reporting on the psychometric properties of these questionnaires; and (3) Psychometric examination of the EPIC-26 rating in 651 Norwegian men treated with RALP at a mean of 3.2 years post-surgery. Results The questionnaire development showed a significant increase in bother versus function items, and the EPIC-26 contains eight function and 18 bother items. Twelve papers concerning the EPIC-26 available on PubMed since 2012 support the psychometric properties of the EPIC-26. The Norwegian EPIC-26 findings supported the psychometric properties of the EPIC-26, but suggested six subdomains both by exploratory and confirmatory factor analyses. Conclusions In general our examinations supported the adequate psychometric properties of the EPIC-26, although the factor structure, construct and predictive validity of the instrument should be examined further.http://link.springer.com/article/10.1186/s12894-017-0302-7Prostate cancerAdverse effectsPatient-reported outcome measuresThe expanded prostate cancer index composite 26 item versionThe UCLA prostate cancer index |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Karol Axcrona Rasmus Nilsson Bjørn Brennhovd Øystein Sørebø Sophie D. Fosså Alv A. Dahl |
spellingShingle |
Karol Axcrona Rasmus Nilsson Bjørn Brennhovd Øystein Sørebø Sophie D. Fosså Alv A. Dahl Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations BMC Urology Prostate cancer Adverse effects Patient-reported outcome measures The expanded prostate cancer index composite 26 item version The UCLA prostate cancer index |
author_facet |
Karol Axcrona Rasmus Nilsson Bjørn Brennhovd Øystein Sørebø Sophie D. Fosså Alv A. Dahl |
author_sort |
Karol Axcrona |
title |
Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations |
title_short |
Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations |
title_full |
Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations |
title_fullStr |
Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations |
title_full_unstemmed |
Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations |
title_sort |
psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations |
publisher |
BMC |
series |
BMC Urology |
issn |
1471-2490 |
publishDate |
2017-12-01 |
description |
Abstract Background Recently, the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26) was recommended for the assessment of adverse effects after the treatment of prostate cancer without clear reasons. This decision encouraged us to review the questionnaire development from the UCLA Prostate Cancer Index (UCLA-PCI) to the EPIC-16 CP with a focus on psychometric properties. We also reviewed PubMed for papers concerning such properties of the EPIC-26 since 2012 (latest review in 2011). Finally, we examined the psychometric properties of the EPIC-26 in a sample of Norwegian males treated with robot-assisted laparoscopic prostatectomy (RALP). Methods This study used three methods: (1) Comparison of the content of the UCLA-PCI, EPIC-50, EPIC-26, and EPIC-16 CP; (2) Review of EPIC-26 and EPIC-16 CP papers in PubMed from 2012 to 2016, identifying papers reporting on the psychometric properties of these questionnaires; and (3) Psychometric examination of the EPIC-26 rating in 651 Norwegian men treated with RALP at a mean of 3.2 years post-surgery. Results The questionnaire development showed a significant increase in bother versus function items, and the EPIC-26 contains eight function and 18 bother items. Twelve papers concerning the EPIC-26 available on PubMed since 2012 support the psychometric properties of the EPIC-26. The Norwegian EPIC-26 findings supported the psychometric properties of the EPIC-26, but suggested six subdomains both by exploratory and confirmatory factor analyses. Conclusions In general our examinations supported the adequate psychometric properties of the EPIC-26, although the factor structure, construct and predictive validity of the instrument should be examined further. |
topic |
Prostate cancer Adverse effects Patient-reported outcome measures The expanded prostate cancer index composite 26 item version The UCLA prostate cancer index |
url |
http://link.springer.com/article/10.1186/s12894-017-0302-7 |
work_keys_str_mv |
AT karolaxcrona psychometricpropertiesoftheexpandedprostatecancerindexcomposite26instrumentinacohortofradicalprostatectomypatientstheoreticalandpracticalexaminations AT rasmusnilsson psychometricpropertiesoftheexpandedprostatecancerindexcomposite26instrumentinacohortofradicalprostatectomypatientstheoreticalandpracticalexaminations AT bjørnbrennhovd psychometricpropertiesoftheexpandedprostatecancerindexcomposite26instrumentinacohortofradicalprostatectomypatientstheoreticalandpracticalexaminations AT øysteinsørebø psychometricpropertiesoftheexpandedprostatecancerindexcomposite26instrumentinacohortofradicalprostatectomypatientstheoreticalandpracticalexaminations AT sophiedfossa psychometricpropertiesoftheexpandedprostatecancerindexcomposite26instrumentinacohortofradicalprostatectomypatientstheoreticalandpracticalexaminations AT alvadahl psychometricpropertiesoftheexpandedprostatecancerindexcomposite26instrumentinacohortofradicalprostatectomypatientstheoreticalandpracticalexaminations |
_version_ |
1725364097965359104 |